This design links nicotine-induced receptor activation to PKA signaling, engagement of the HA–CD44 pathway, and constraint by p53, culminating in elevated secreted VEGF and, consequently, greater cell survival with reduced apoptosis in NSCLC cells. Here, TP53 is linked to non-small cell lung carcinoma.